Trial intelligence / Profile preview

Plasma Rich Fibrin Epidural Injection for Postdural Puncture Headache

NCT06790758Completed

Sponsor
Tanta University
Start
Jan 2025
Primary completion
Nov 2025
Modality
Device-based Delivery
Countries
1
01

Overview

Open-label, single-arm trial of platelet rich fibrin in post-dural puncture headache (PDPH), sponsored by Tanta University. Primary endpoint: Success rate of the procedure at 24 hours. Started Jan 2025; status: completed.

02

Drugs

platelet rich fibrin
03

Conditions

post-dural puncture headache (PDPH)

Beyond the preview

Go deeper on NCT06790758.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06790758.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call